Australia markets open in 9 hours 49 minutes

Vaccitech plc (VACC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
4.8000+0.2600 (+5.73%)
As of 09:41AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 168.89M
Enterprise value -24.97M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)11.20
Price/book (mrq)0.67
Enterprise value/revenue -1.66
Enterprise value/EBITDA 0.77

Trading information

Stock price history

Beta (5Y monthly) N/A
52-week change 3-71.92%
S&P500 52-week change 3-0.65%
52-week high 317.9900
52-week low 32.9700
50-day moving average 35.1002
200-day moving average 310.5366

Share statistics

Avg vol (3-month) 320.98k
Avg vol (10-day) 350.04k
Shares outstanding 537.2M
Implied shares outstanding 6N/A
Float 825.4M
% held by insiders 127.55%
% held by institutions 18.57%
Shares short (28 Apr 2022) 45.61k
Short ratio (28 Apr 2022) 40.42
Short % of float (28 Apr 2022) 4N/A
Short % of shares outstanding (28 Apr 2022) 40.02%
Shares short (prior month 30 Mar 2022) 412.29k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Dec 2021

Profitability

Profit margin 0.00%
Operating margin (ttm)-15,380.60%

Management effectiveness

Return on assets (ttm)-15.55%
Return on equity (ttm)-40.99%

Income statement

Revenue (ttm)268k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-20.1M
EBITDA -40.8M
Net income avi to common (ttm)-50.87M
Diluted EPS (ttm)-1.9640
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)214.05M
Total cash per share (mrq)5.76
Total debt (mrq)7.22M
Total debt/equity (mrq)2.86
Current ratio (mrq)20.32
Book value per share (mrq)6.78

Cash flow statement

Operating cash flow (ttm)-32.58M
Levered free cash flow (ttm)-16.54M